Damage to the central nervous system from trauma could be reversed with the help of a new antibody.
The new antibody works by blocking the effects of a molecule called lysophosphatidic acid (LPA) that is released in response to injury, promoting inflammation leading to scarring and nerve cell death.
Administering the antibody shortly after the injury could preserve nerve cells, limit scarring and reduce loss in motor function.
This study is not the first to look at the effects of LPA after neurotraumatic events and researchers said it could lead to better outcomes for patients in the future.
Read more at Monash University